Efficacy and Safety of Rituximab Therapy to Sustain Remission in Young Children With Childhood Nephrotic Syndrome.

Chan EY, Au CT, Yu EL, Angeletti A, Arslan Z, Boyer O, Chan CY, Colucci M, Dorval G, Dossier C, Ghiggeri GM, Hamada R, Hogan J, Ishikura K, Kamei K, Kemper MJ, Ma AL, Parekh RS, Radhakrishnan S, Robinson C, Shen Q, Sinha R, Subun C, Teo S, Vivarelli M, Webb H, Xu H, Yamamura T, Yap HK, Tullus K

Open source

DOI: 10.1016/j.ekir.2026.106526
Published: 2026 Jun
Container: Kidney international reports
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ekir.2026.106526,
  title = {Efficacy and Safety of Rituximab Therapy to Sustain Remission in Young Children With Childhood Nephrotic Syndrome.},
  author = {Chan EY and Au CT and Yu EL and Angeletti A and Arslan Z and Boyer O and Chan CY and Colucci M and Dorval G and Dossier C and Ghiggeri GM and Hamada R and Hogan J and Ishikura K and Kamei K and Kemper MJ and Ma AL and Parekh RS and Radhakrishnan S and Robinson C and Shen Q and Sinha R and Subun C and Teo S and Vivarelli M and Webb H and Xu H and Yamamura T and Yap HK and Tullus K},
  year = {2026},
  journal = {Kidney international reports},
  doi = {10.1016/j.ekir.2026.106526},
  url = {https://doi.org/10.1016/j.ekir.2026.106526}
}

RIS

TY  - JOUR
TI  - Efficacy and Safety of Rituximab Therapy to Sustain Remission in Young Children With Childhood Nephrotic Syndrome.
AU  - Chan EY
AU  - Au CT
AU  - Yu EL
AU  - Angeletti A
AU  - Arslan Z
AU  - Boyer O
AU  - Chan CY
AU  - Colucci M
AU  - Dorval G
AU  - Dossier C
AU  - Ghiggeri GM
AU  - Hamada R
AU  - Hogan J
AU  - Ishikura K
AU  - Kamei K
AU  - Kemper MJ
AU  - Ma AL
AU  - Parekh RS
AU  - Radhakrishnan S
AU  - Robinson C
AU  - Shen Q
AU  - Sinha R
AU  - Subun C
AU  - Teo S
AU  - Vivarelli M
AU  - Webb H
AU  - Xu H
AU  - Yamamura T
AU  - Yap HK
AU  - Tullus K
PY  - 2026
JO  - Kidney international reports
DO  - 10.1016/j.ekir.2026.106526
UR  - https://doi.org/10.1016/j.ekir.2026.106526
ER  -

APA

EY, C., CT, A., EL, Y., A, A., Z, A., O, B., CY, C., M, C., G, D., C, D., GM, G., R, H., J, H., K, I., K, K., MJ, K., AL, M., RS, P., S, R., C, R., Q, S., R, S., C, S., S, T., M, V., H, W., H, X., T, Y., HK, Y., & K, T. (2026). Efficacy and Safety of Rituximab Therapy to Sustain Remission in Young Children With Childhood Nephrotic Syndrome.. Kidney international reports. https://doi.org/10.1016/j.ekir.2026.106526

Source records

pubmed · retrieved 2026-09-26T15:15:12.490Z